Search

Australian Government Department of Health and Ageing, Children's Hospital Foundation, Cystic Fibrosis Foundation, Newcastle University, Griffith University, Erasmus Medical Center, Monash University, University of Copenhagen, Hôpital Cochin, South Australian Health and Medical Research Institute, University of Melbourne, James Cook University, Queensland, Australia, Murdoch Childrens Research Institute, and Claire Wainright, Professor

Newcastle University, European Fruit Juice Association (AIJN), and Courtney Neal, Research Assistant

Norton Physiotherapy, Newcastle University, and Alasdair MacSween, Principal Lecturer (Research and Innovation)

Newcastle University and Paul Chesterton, Professor

Nationwide Children's Hospital, Washington University School of Medicine, University of Iowa, University of Florida, University of Minnesota, Newcastle University, University of Kansas Medical Center, University of Colorado, Denver, Indiana CHC (Community Health Clinic), and University of California, Irvine

Newcastle University, Nationwide Children's Hospital, Washington University School of Medicine, University of Iowa, University of Minnesota, University of California, Irvine, Hugo W. Moser Research Institute at Kennedy Krieger, Inc., University of Colorado, Denver, and University of Kansas Medical Center

Chinese University of Hong Kong, University of Edinburgh, University of Seville, Imperial College London, Icahn School of Medicine at Mount Sinai, Fundacio Clinic Barcelona, Sorbonne University, and Newcastle University

Newcastle University, University of Cambridge, University of Novi Sad, University of Florence, University of Regensburg, Utrecht University, Utrecht, the Netherlands., Servicio Madrileño de Salud, Madrid, Spain, and Djordje Jakovljevic, Professor

British Heart Foundation and Newcastle University

University of Ghana, Newcastle University, Penn State University, and Helen Keller International

King's College London, University College, London, Imperial College London, University of Cambridge, University of Southampton, University of Nottingham, University of Leicester, Frimley Health NHS Foundation Trust, Newcastle University, University of Bristol, and Asthma and Lung UK

Newcastle University and Ioannis Vogiatzis, Professor of Rehabilitation Sciences

Imperial College Healthcare NHS Trust, Royal Marsden NHS Foundation Trust, University of Manchester, The Christie NHS Foundation Trust, Invicro, and Newcastle University

University of Liverpool, University of Manchester, Newcastle University, University of Nottingham, University of Sheffield, and Philip Quirke, Professor Philip Quirke

University of Nottingham, Newcastle University, Queen Mary University of London, and Cheryl Battersby, Clinical Senior Lecturer

Newcastle University, University of Nottingham, University of Cambridge, University of Seville, Pinnacle Clinical Research, PLLC, ICAN Nutrition Education and Research, Assistance Publique - Hôpitaux de Paris, University of Angers, University of Palermo, University of Turin, Italy, University Medical Center Mainz, University of Helsinki, University of Bern, Linkoeping University, Perspectum, Antaros Medical, Resoundant Inc, Pfizer, Novartis, Takeda, Boehringer Ingelheim, Intercept Pharmaceuticals, and Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Newcastle University

Fundació Institut Germans Trias i Pujol, University Hospital Munich, University Hospital, Bonn, University of Kiel, University Hospital Tuebingen, University of Padova, Ludwig-Maximilians - University of Munich, Medical University of Gdansk, Cliniques universitaires Saint-Luc- Université Catholique de Louvain, Motol University Hospital, Prague, Rennes University Hospital, Children's University Hospital, Ireland, University of Oslo, Princess Maxima Center for Pediatric Oncology, Andaluz Health Service, Swiss Pediatric Oncology Group, Gothia Forum - Center for Clinical Trial, The Leeds Teaching Hospitals NHS Trust, Bambino Gesù Hospital and Research Institute, Newcastle University Centre for Cancer, Newcastle, Experimental Cancer Medicine Centres, and XenTech, Evry

University of Manchester, Northumbria Healthcare NHS Foundation Trust, Newcastle University, and Reason Digital

Newcastle University and Technische Universität Dresden

University of Aberdeen, NHS Greater Glasgow and Clyde, University of East Anglia, Nottingham City Hospital, Swansea University, Newcastle University, University of Cambridge, NHS Sunderland Clinical Commissioning Group, Liverpool School of Tropical Medicine, Royal Brompton & Harefield NHS Foundation Trust, University College London Hospitals, Liverpool Heart and Chest Hospital NHS Foundation Trust, Imperial College London, Red Graphic, Eramol (UK) Ltd., WGK Clinical Services Ltd., Sealed Envelope Ltd., National Institute for Health Research, United Kingdom, and Dr Ian B Wilkinson, Professor of Therapeutics

University of Leicester, University of Glasgow, Newcastle University, British Lung Foundation, British Pigeon Fanciers Medical Research, and Mark Spears, Dr Mark Spears, Consultant in Respiratory Medicine

University of Manchester, Newcastle University, University of Oxford, The Leeds Teaching Hospitals NHS Trust, Beatson West of Scotland Cancer Centre, University of Glasgow, Velindre NHS Trust, University College London Hospitals, Queen's University, Belfast, and University of Sheffield

Newcastle University, University of Durham, and Newcastle-upon-Tyne Hospitals NHS Trust

Newcastle University, Chiesi UK, and GlaxoSmithKline

North Wales Organisation for Randomised Trials in Health, Newcastle University, and Medtronic

County Durham and Darlington NHS Foundation Trust, Sheffield Teaching Hospitals NHS Foundation Trust, Newcastle University, and Durham University

Newcastle University

University of Central Lancashire, Aston University, University of Birmingham, University of Bradford, De Montfort University, University of Greenwich, University of Huddersfield, Kingston University, Newcastle University, Queen's University, Belfast, Robert Gordon University, University of Ulster, University of Wolverhampton, and Andrew Lunn, Lecturer in Clinical Pharmacy

European Commission, Simbec-Orion Group Ltd, Merthyr Tydfil, UK, Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany, Leiden University Medical Center, LUMC, Leiden, The Netherlands, Centre Hospitalier Universitaire de Nancy, CHU, Vandoeuvre-Lès-Nancy, France, Ghent University Hospital, UZG, Ghent, Belgium, Ospedale Pediatrico Bambino Gesù, OPBG, Rome, Italy, Newcastle University, UNEW, Newcastle, UK, Vall d'Hebron Institute of Oncology (VHIO) and Banc de Sang I Teixits (BST), Barcelona, Spain, and Prof. Tobias Feuchtinger, Prof. Dr. med Tobias Feuchtinger

European Society for Paediatric Infectious Diseases, Medical University of Graz, University Hospital Munich, National and Kapodistrian University of Athens, Mitera Hospital, Children's hospital Iceland, University of Padova, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Riga Stradins University, Maasstad Hospital, HagaZiekenhuis, Leiden University Medical Center, Wroclaw Medical University, University Medical Centre Ljubljana, Hospital Clínico Universitario de Santiago de Compostela, Hospital Universitario 12 de Octubre, Hospital Universitario La Paz, Gregorio Marañón Hospital, Karolinska Institutet, Imperial College London, University of Liverpool, Newcastle University, and Dorine Borensztajn, Principal investigator, MD, PhD, MSc.

University of Nottingham, University Hospitals Bristol and Weston NHS Foundation Trust, Newcastle-upon-Tyne Hospitals NHS Trust, University of Exeter, Great Ormond Street Hospital for Children NHS Foundation Trust, University of Surrey, Newcastle University, University of Bristol, and DNA-v International

Macmillan Cancer Support, University of Kansas, Bishop Grosseteste University, and Newcastle University

University of Glasgow, Fundacion Clinic per a la Recerca Biomédica, and Newcastle University

University of Reading, King's College London, University of Roehampton, University of Pennsylvania, Newcastle University, and Dr Maria Loades, Clinical Psychologist, Reader in Clinical Psychology

King's College London, University of Glasgow, Cornell University, Queen Mary University of London, Newcastle University, and University of Bristol

University of Nottingham, Queen Elizabeth University Hospital Glasgow, Royal Infirmary of Edinburgh, University of Edinburgh, Newcastle University, Newcastle-upon-Tyne Hospitals NHS Trust, University of Leeds, The Leeds Teaching Hospitals NHS Trust, Sheffield Teaching Hospitals NHS Foundation Trust, University of Sheffield, Northern Care Alliance NHS Foundation Trust, University College, London, University of Cambridge, and Cambridge University Hospitals NHS Foundation Trust

European Union, Cooperative International Neuromuscular Research Group, Newcastle University, and University of Pittsburgh

King's College London, Newcastle University, and London School of Hygiene and Tropical Medicine

The National Screening Service, Newcastle University, University College, London, University of Dublin, Trinity College, and Nicholas Clarke, Principal Investigator

Newcastle University, University Medical Center Freiburg, National Institute of Neurological Disorders and Stroke (NINDS), and Robert Griggs, MD, Professor of Neurology

Newcastle University, Qassim University, and Majid Alotni, PhD student

GlaxoSmithKline, Nordic Bioscience A/S, University of Surrey, Leiden University Medical Center, Complexo Hospitalario Universitario de A Coruña, Institut de Recherches Internationales Servier, Newcastle University, Merck KGaA, Darmstadt, Germany, Diakonhjemmet Hospital, Assistance Publique - Hôpitaux de Paris, and F.P.J.G. Lafeber, Professor, director of research

Newcastle University, UK, Vervig (IoM), and Jutta Mari Adelin Jorgensen, Principal Investigator of ZanStroke, Dr. Jutta Mari Adelin Jorgensen

Newcastle University, UK, University of Copenhagen, National Institute for Medical Research, Tanzania, Nutrition Centre of the Philippines, University Teaching Hospital, Lusaka, Zambia, and Delhi University

Social Sciences and Humanities Research Council of Canada, University of Victoria, Newcastle University, and Mark Beauchamp, Professor of Kinesiology

University of Ghana, Newcastle University, Penn State University, and Helen Keller International

GlaxoSmithKline, Medical Research Council, Imperial College London, University College, London, Newcastle University, University of Glasgow, University of Cambridge, and Rachel Jones, Consultant Nephrologist

Maastricht University, University of Iowa, Johns Hopkins University, Newcastle University, University of Sydney, and Vordenberg, Clinical Associate Professor

Sheffield Hallam University, Newcastle University, Teesside University, and Will Evans, Principle Investigator